All articles tagged with #hpv vaccine
Originally Published 2 months ago — by NPR
Pakistan's first HPV vaccination campaign aimed at girls aged 9-14 faced significant resistance due to misinformation, cultural sensitivities, and skepticism, resulting in about 70% vaccination coverage instead of the targeted 90%, highlighting challenges in public health efforts in the country.
Originally Published 2 months ago — by Al Jazeera
Pakistan's first national HPV vaccine campaign faced resistance due to misinformation, conspiracy theories, and cultural concerns, despite the vaccine's safety and importance in preventing cervical cancer, with efforts including public vaccination and government support to increase acceptance.
Originally Published 3 months ago — by Dawn
Misinformation and conspiracy theories in Pakistan have led to low uptake of the HPV vaccine aimed at preventing cervical cancer, with false claims about infertility causing parents to refuse vaccination for their daughters, hindering the campaign's success.
Originally Published 5 months ago — by AOL.com
The article emphasizes the importance of the HPV vaccine in preventing HPV-related cancers, including cervical and oral cancers, highlighting that public awareness remains low despite the vaccine's high efficacy. It discusses HPV transmission, the safety and timing of vaccination, and addresses misconceptions about encouraging early sexual activity, urging increased education and awareness to reduce HPV-related cancer rates.
Originally Published 5 months ago — by CNN
The article emphasizes the importance of the HPV vaccine in preventing HPV-related cancers, highlights the low public awareness about HPV, and discusses the vaccine's high efficacy and recommended administration age, while addressing common misconceptions and the need for increased education.
Originally Published 5 months ago — by The Irish Times
Ireland is launching a school-based HPV vaccine catch-up programme to benefit up to 75,000 students, aiming to prevent HPV-related cancers, with efforts to extend vaccination access to those under 25 who missed initial doses, despite concerns over costs for some individuals.
Originally Published 6 months ago — by GhanaWeb
Dr. Julian Nii Ardey Ansah emphasizes the high effectiveness and safety of the HPV vaccine in preventing cervical and other cancers, urging early vaccination for children aged 9-14 and catch-up doses for older individuals, to protect against HPV-related diseases.
Originally Published 1 year ago — by ScienceAlert
Cervical cancer deaths among young American women have dropped by 62% in the last decade, largely attributed to the Gardasil HPV vaccine. The vaccine, approved in 2006, targets strains of HPV responsible for 70% of cervical cancers. Despite the success, HPV vaccination rates in the US have stagnated, highlighting the need for improved coverage. The study, published in JAMA, underscores the vaccine's potential to prevent various cancers, not just cervical, and calls for broader vaccination efforts.
Originally Published 1 year ago — by ABC News
A new study highlights the significant impact of the HPV vaccine in reducing the risk of multiple cancers in men, including head and neck cancers. Initially targeted at preventing cervical cancer in women, the vaccine is now recommended for boys and young men, showing promising results in cancer prevention. Despite increasing vaccination rates, experts emphasize the need for higher uptake to meet public health goals and maximize the vaccine's benefits.
Originally Published 1 year ago — by KSL.com
A new analysis of over 3.4 million people shows that vaccinating boys and men against HPV significantly reduces their risk of head and neck cancers and other malignancies, extending the known benefits of the vaccine beyond cervical cancer prevention in women. The study highlights the importance of HPV vaccination for both genders, with vaccinated males showing notably lower rates of HPV-related cancers.
Originally Published 1 year ago — by New York Post
New research indicates that the HPV vaccine is effective in preventing cancer in both men and women, though fewer boys are getting vaccinated compared to girls in the U.S. The study found that vaccinated men had a lower risk of developing HPV-related cancers, such as those of the mouth and throat. Despite rising vaccination rates, males still lag behind females in receiving the HPV shots. Experts emphasize the importance of vaccinating both boys and girls to reduce cancer risk.
Originally Published 1 year ago — by NBC News
New research suggests that the HPV vaccine significantly reduces the risk of head and neck cancers in men, with vaccinated males showing a 54% lower risk of HPV-related cancers. The study, which analyzed health records of nearly 3.5 million people, highlights the importance of HPV vaccination for both males and females in preventing various cancers. The findings will be presented at the American Society of Clinical Oncology conference.
Originally Published 1 year ago — by The New York Times
Merck's production problem will result in the delivery of only 18.8 million out of the 29.6 million contracted doses of the HPV vaccine to low- and middle-income countries in 2024, leaving over 10 million girls without their expected shots. This delay means that 1.5 million teenage girls in some of the world’s poorest countries will miss the chance to be protected from cervical cancer, as they will be too old to qualify for the vaccine in subsequent years. Merck has attributed the delay to a manufacturing disruption and plans to deliver the delayed doses in 2025, while also shipping 30 million doses of the vaccine to Gavi-supported countries this year, including some doses that were supposed to have been sent in 2023.
Originally Published 1 year ago — by The Atlanta Journal Constitution
Georgia and California are working to increase HPV vaccination rates, as the U.S. falls short compared to countries like Australia and the UK. Efforts include informing parents about the vaccine's ability to prevent several types of cancer, sending letters to parents, and emphasizing parent-doctor cooperation. Experts stress the importance of normalizing vaccine uptake and addressing the taboo around discussing HPV. Additionally, there are recommendations for HPV vaccination and testing, with efforts to increase outreach to adults as well.
Originally Published 1 year ago — by World Health Organization (WHO)
Governments, donors, and partners have announced nearly US$600 million in new funding and major commitments to eliminate cervical cancer, marking a historic step towards ending the preventable disease. The first-ever Global Cervical Cancer Elimination Forum in Colombia catalyzed national and global momentum to expand vaccine coverage and strengthen screening and treatment programs. With the knowledge and tools already in existence, including the HPV vaccine, there is potential to eliminate cervical cancer for the first time. However, challenges such as supply constraints, delivery issues, and the COVID-19 pandemic have hindered progress, leading to deep inequity, particularly in low and middle-income countries. The commitments made at the forum aim to reverse this trend and prevent annual deaths from rising to 410,000 by 2030.